Another lifetime sales figure that should really stand out is AbbVie 's(NYSE: ABBV) anti-inflammatory drug Humira, which is currently in second place with $95.6 billion in lifetime sales. This $53 billion gap between Humira and Lipitor might appear insurmountable, but it's possible that Humira could pass Lipitor by as early as 2020 for the title of most lifetime sales. Humira is approved in 10 indications, and it generated more than $16 billion in sales for AbbVie last year alone (the single-best year for any prescription drug on record). The big question mark is whether AbbVie can keep bio competition on the sidelines. If it can, Humira has a path to become the best-selling drug ever.
-
Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page
Humira $95.6 Billion and Still Going
- Thread starter anonymous
- Start date
-
- Tags
- None
So we are the World record holders SWEET ! Based on this trend, we are on track to sell $64B MORE from now to 2020.
AbbVie spent $34.30 million last month for the TV ad campaign for Humira with three different indications and a variety of spots for each. It's wall to wall plastered on every channel 24/7. Marketing is milking this golden cow like mad. that's why we'll surpass Lipitor by 2020.
Amgens Bio Amgevita is dead in the water in EU for at least a year, and dead in U.S. Until 2020. We hold patent protection in the EU until April 2018 and it will be a long desperately struggle to launch the biosimilars in European markets and they won't succeed any time soon. Rick already stepped on them in U.S. By filing an infringement lawsuit. Out of the $16B in sales only $5B is in EU with $10B in U.S. Don't believe the fake news about this. Amgen didn't have the balls to do at risk launch like they hinted about back in December. NONE of the single switch studies that are being done now would meet the FDA's standard. EVEN If Amgen somehow managed to launch in EU in May 2018, Wall Street consensus for impact on stock would be ONLY $4 decline based on current $66 price Ricks a genius
-Yo Before I was fired for cause one of my customers said the price for Amgevita and other generics won't be that much less than Humira for a couple of years but once there is more generic competition the prices will drastically fall. The clock is ticking nonetheless and for me it stopped ticking after I was let go....... Stock and Vpuke going down.....Wish I was still working here Team ...Go Cubs
Back in early November ABBV was at $56.31, today shares are $65.37 a nice gain of 15.9%.
Making me some easy $$$
My friend, please hold it longer, my financial analyst says its 12 month target price is $90. I am buying a block of 500 shares even at current prices.
Back in early November 2014 ABBV first broke through $65.37,
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>the same price as today 29 months later
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>the same price as today 29 months later
Nice play, I'm holding 10,000 got in @$58 in November... Gained 72K in 5 months,
My friend, please hold it longer, my financial analyst says not to look at actual results......
My friend, please hold it longer, my financial analyst says not to look at actual results......
ABBV is up 27.13% since hitting lows of $55.06 on October 28 the stock will enter into a new bull market after finding strong support between $64.46 and $64.74. In terms of pullbacks, $65.45 level is the first resistance point. I see key technical price levels in the stock. UP UP AND AWAY WE GO !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
- when is the best time to buy puts against earnings?
NOW... ABBV failed against resistance... will probably be in a risk off downward slide until earnings
look @ Jun2017 puts @60, which may easily gain 25-50% by EOM
NOW... ABBV failed against resistance... will probably be in a risk off downward slide until earnings
look @ Jun2017 puts @60, which may easily gain 25-50% by EOM
IM with you on this one ... ABBV rallied against resistance... will probably be in upward climb until earnings
Thank Heaven that Dr. Leiden championed the acquisition of Hurmira! We need him back!
My old colleague Jeff is CEO at Vertex ...Y'all trolls are hillarious grasping for straws on here. Yes we were on executive steering committee for Humira launch. Watch ya gonna do about it little man ?
I had $5M in options while you were still sucking on your mommas tit. Now dream on brother !!